Jefferies analyst Ashley Helgans downgraded Estee Lauder to Hold from Buy with a price target of $190, down from $270. Growing concerns around the recovery of Estee’s key growth drivers in China skincare have led the analyst to cut estimates 10% below consensus for fiscal 2024. The company’s China sales and a new Tmall data set point to “prolonged recovery,” and concentration in the region will be hard to offset in U.S., where the company’s brands are losing share, the analyst tells investors in a research note. The firm adds that a cycle shift to makeup from skincare and skincare trade down will pressure Estee Lauder’s margins.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EL:
- Tesla downgraded, Netflix upgraded: Wall Street’s top analyst calls
- Estee Lauder downgraded to Neutral from Overweight at Piper Sandler
- Estee Lauder price target lowered to $210 from $235 at TD Cowen
- Estee Lauder downgraded, AB InBev upgraded: Wall Street’s top analyst calls
- Estee Lauder downgraded to Equal Weight from Overweight at Barclays